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Abstract 
Introduction: Determination of the true prevalence of Helicobacter pylori (H. pylori) is difficult in a hyper-endemic area like Nigeria with use of 
serological tests because of their low discriminatory power between previous and current infections. The use of biopsy based methods will go a 
long way to mitigate this problem. We investigated the prevalence of H. pylori in dyspeptic patients and its relationship with gastroduodenal 
pathologies using gastric biopsy histology and rapid urease test. Methods: Eighty-six consecutive adult patients with dyspepsia underwent upper 
gastrointestinal  endoscopy  using  forward-viewing  endoscopes.  Antral  biopsy  specimens  were  collected  for  histology  and  rapid  urease  test. 
Diagnosis of H. pylori infection was made if both or either of the tests was positive. Results: Of the 86 subjects, there were 39 (45.3%) males and 
47(54.7%) females. The age range was 23 to 85 years with a mean of 49.19±13.75 years. Diagnosis of H. pylori was made in 55(64%) patients. 
Gastritis was the commonest endoscopic finding (60.5%), serious gastroduodenal pathology (gastric ulcer, duodenal ulcer and gastric cancer) were 
documented in only 12 (14%) patients. Thirty three (63.5%) of the 55 patients with gastritis had H. pylori infection while 7(58.3%) of the 12 
patients with serious gastroduodenal lesions had the infection. Thirteen (72.2%) of the 18 patients that had normal endoscopic findings were H. 
pylori positive. Conclusion: The prevalence of H. pylori among dyspeptics using biopsy based methods is high in the South-Western part of 
Nigeria. It is therefore important to test and treat H. pylori among Nigerians with dyspepsia. 
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Introduction 
 
The discovery of Helicobacter pylori (H. pylori) by Warren and Marshall, in 1983 was a major breakthrough in the management of dyspepsia [1]. H. 
pylori is a gram negative, spiral, flagellated bacterium with a capability for abundant urease production which has been implicated in several upper 
gastrointestinal  diseases  that  present  as  dyspepsia  [2,3].  The  organism  is  usually  found  under  the  mucus  layer  in  the  gastric  pits  in  close 
apposition to gastric epithelial cells where it causes damage to the cells [4]. It is a major aetiological factor in chronic gastritis, peptic ulcer 
disease, gastric carcinoma, and gastric mucosal associated lymphoid tissue (MALT) lymphoma [2,3]. Peptic ulcer disease is now viewed as an 
infectious disease since eradication of H. pylori leads to its cure [4].  
  
Various diagnostic tests for H. pylori have been developed and they can be broadly classified into invasive and non-invasive tests [4]. Invasive 
tests utilize endoscopic biopsy samples for histology, culture, rapid urease test (RUT) and polymerase chain reaction. All these tests have been 
found to have sensitivity and specificity that are well above 90% [5].  
  
The non-invasive tests do not require endoscopy. These include urea breath test (UBT), immunoglobulin G and M serology, stool antigen test, 
saliva antibody test and urinary antibody test [4]. In Nigeria, the non-invasive tests are not generally available except Immunoglobulin G (IgG) 
serology. The value of serological tests in a hyper-endemic area like Nigeria is limited, because of their low discriminatory power between previous 
and current infection.  
  
The aim of this study was to determine the prevalence of H. pylori among dyspeptic patients seen at the University College Hospital, Ibadan and 
its association with gastroduodenal pathologies using gastric biopsy histology and rapid urease test. The hospital serves as a referral centre for a 
substantial part of the South-Western region of Nigeria. 
  
 
 
Methods 
 
The study was carried out at the Endoscopy sub-unit of the Gastrointestinal & Liver Unit, Department of Medicine, University College Hospital 
(UCH), Ibadan, Nigeria. 
  
Ethical clearance was sought and obtained from the Joint University of Ibadan/ University College Hospital Institutional Review Committee. Eighty-
six consecutive adult patients with dyspeptic symptoms undergoing endoscopy from April 2008 to February 2009 were recruited after obtaining 
informed consent from them. Patients who were previously treated for H. pylori infection or who had received antibiotics, proton pump inhibitors or 
bismuth compounds in the preceding 4 weeks were excluded. Base line bio-data were obtained. 
  
Oesophago-gastro-duodenoscopy (OGD) was performed on all the participants using Olympus (GFI-XQ20) or Pentax (FG29W) forward-viewing 
Oesophago-gastro-duodenoscope.  Endoscopic  features  of  each  patient  were  recorded.  Endoscopic  appearance  was  considered  normal  if  the 
mucosal was pink in colour, smooth and lustrous. Two gastric antral mucosal biopsies were taken for each of RUT and histology. A diagnosis of H. 
pylori infection was made when both or one of these two tests was positive. 
  
Rapid urease test (RUT) 
  
Two of the four antral biopsies taken from each patient were used immediately for RUT using GUT-plus by Albyn medical, Smart Medical Group,UK. 
GUT plus is a new generation RUT kit that consists of two dry filter paper containing urea and phenol red (a pH indicator) in a sealed plastic slide. 
If the urease enzyme of H. pylori is present in an inserted tissue sample, the resulting decomposition of urea to CO2 and NH3 causes the pH to 
rise  and  the  colour  of  the  dot  turns  from  yellow  to  a  bright  magenta.  Results  were  read  within  3  hours  after  sampling  according  to  the Page number not for citation purposes  3 
manufacturer’s specification. Colour change from yellow to magenta was considered a positive result while no colour change was regarded as 
negative. 
  
Histology 
  
The other two antral biopsies were fixed in 10% formaldehyde and transferred to the histopathology laboratory for processing. Four micron thick 
paraffin sections were stained with routine Haematoxylin and Eosin for detection of H. pylori and gastritis. Giemsa stain was also used for better 
yield. Slides were examined microscopically for H. pylori by the Pathologist. Presence of Helicobacter-like organisms was regarded as positive while 
absence was regarded as negative. 
  
Data analysis 
  
Data was analyzed using Statistical Package for Social Sciences, version16.0 (SPSS Inc. Chicago Illinois). Results were presented as means ± 
standard  deviation  for  quantitative  variables  and  number  (percentages)  for  qualitative  variables.  Categorical  variables  were  compared  with 
Pearson’s Chi-square. Significant P-value was taken as <0.01.  
 
 
 
Results 
 
There were 39 (45.3%) males and 47(54.7%) females. The mean age was 49.19 (±13.75) years. The age ranged from 23 to 85 years. Forty-five 
(52.35%) and 52 (60.5 %) patients were H. pylori positive with histology and RUT respectively. Fifty-five (64%) patients were positive when 
results of both tests were combined. 
  
The  most  common  abnormality  at  endoscopy  was  gastritis  which  was  seen  in  52  (60.5%)  patients,  followed  by  duodenitis  16(18.6%)  and 
doudenogastric reflux 14(16.3%). Gastric ulcer (GU) was recorded in 8(9.3%) patients, 7(8.1%) patients had oesophagitis, while 3(3.5%) and 
2(2.3%) patients had gastric cancer and duodenal ulcer (DU) respectively. Serious gastroduodenal pathologies (GU, DU and gastric cancer) were 
documented in only 12 (14%) patients. It is noteworthy however, that there was a considerable overlap in the endoscopic findings in these 
subjects as many of them with other endoscopic lesions also had gastritis. 
Sixty-eight (79.1%) patients had endoscopically identifiable cause for their dyspepsia while the remaining 18(20.9%) had normal endoscopic 
findings. Forty -two (76.4%) patients among those with abnormal endoscopic appearance had H. pylori while 13 (72.2%) of those with normal 
endoscopic findings were positive for the organism. There was no significant difference (P-value = 0.41) between the frequency of H. pylori among 
those with endoscopic abnormality and those with normal findings. Table 1 shows the spectrum of endoscopic findings, while table 2 shows the 
association between H. pylori status and the presence of endoscopic abnormality. 
 
The association between H. pylori status and various endoscopic abnormalities is depicted in table 3. 33(63.5%) out of the 52 patients with 
gastritis had H. pylori infection, while 8 (50%) out of 16 and 7(58.3%) out of 12 patients with duodenitis and serious gastrointestinal lesions 
respectively had H. pylori infection. These relationships however were not statistically significant. 
 
 
 
 
 
 Page number not for citation purposes  4 
Discussion 
  
In this study, H. pylori was diagnosed in 64% of the patients. This is consistent with results of previous studies conducted in Nigeria and other 
parts of West Africa which have consistently shown a high prevalence of H. pylori with the use of biopsy based methods [6-11]. Previous studies 
conducted in various parts of South-Western Nigeria (including the University College Hospital, Ibadan) in which patients were investigated for H. 
pylori  with  the  use  of  either  histology  or  campylobacter-like  organism  (CLO)  test  showed  prevalence  rates  of  60.5%  to  73%  [6,7,12]  . 
Seroprevalence studies conducted in the same region showed prevalence rates as high as 88% to 94.5% [3,13]. These are not unexpected in a 
hyper-endemic area like Nigeria since serological tests cannot discriminate between previous and current infections. The sero-prevalence assay’s 
IgG antibody lasts for up to 3 years or more in the serum even after the organism has been eradicated.  
  
The most common identifiable lesion at endoscopy in this study was gastritis which had a frequency of 60.5%. This is comparable to a frequency 
of 60% obtained in a previous study conducted in the North-Eastern part of Nigeria [9]. An earlier study conducted at the University College 
Hospital, Ibadan showed a frequency of 13.4% for gastritis while normal mucosal was the commonest finding with a frequency of 53% [14]. This 
disparity may be as a result of a change in the pattern of presentation of endoscopic lesions among patients with dyspepsia in more than two 
decades after the conduct of the previous study.  
Our  study  showed  that  despite  the  high  prevalence  of  H.  pylori  infection  in  the  South-Western  part  of  Nigeria,  the  prevalence  of  serious 
gastroduodenal pathologies (GU, DU and gastric cancer) was low as these lesions were documented in only 14% of all the patients. This is 
consistent with findings of previous studies conducted at the same centre and in the North-Eastern part of Nigeria [9,14].  
  
In addition, this study showed that 63.5% of patients with endoscopic gastritis had H. pylori infection. This is consistent with previous studies in 
Nigeria  that  showed  a  high  prevalence  of  H.  pylori  among  patients  with  gastritis  [6,9].  Also,  among  patients  with  serious  gastroduodenal 
pathologies (GU, DU and gastric cancer) 58.3% had H. pylori infection. This finding corroborates the results from similar studies conducted in 
Nigeria and other parts of Africa [6,8,9,15].  Although the association of these lesions with H. pylori infection was not statistically significant, a 
further study involving a larger number of patients is needed to establish the true association between the infection and the lesions. 
  
It was noted  that 13 (72.2%) of the 18 subjects with normal endoscopic findings were positive for H. pylori and no statistically significant 
difference existed in the frequency of H. pylori infection among patients with abnormal endoscopic findings and those with normal findings . This 
could be explained by the very high H. pylori prevalence among Nigerians [13,16] and may suggest that the infection was responsible for the 
symptoms of dyspepsia in such patients. Hence such H. pylori positive patients should be treated with anti-H. pylori therapy. 
  
One major limitation of this study is that it was conducted in a hospital setting and may not be a true representation of the prevalence of H. pylori 
among  dyspeptics  in  the  general  population  of  the  South-Western  Nigeria,  more  so,  that  the  study  was  carried  out  only  in  one  centre.  A 
community study is therefore desirable as this is usually more representative.  
 
 
 
Conclusion 
 
This study shows that the prevalence of H. pylori among dyspeptic patients using biopsy based methods is high in the South-Western part of 
Nigeria. It also suggests that gastritis is the commonest lesion seen at endoscopy among patients with dyspepsia and that despite the high 
prevalence of H. pylori infection in the South-Western part of Nigeria, the prevalence of serious gastroduodenal pathology (GU, DU and gastric 
cancer) is low. Of note is the high prevalence of H. pylori in endoscopically normal patients. It is therefore important to test and treat H. pylori 
among Nigerians with dyspepsia. 
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 Table 1: Upper gastrointestinal endoscopy findings in adult Nigerian patients with dyspepsia 
Variables  Frequency (n=86) 
Present  Absent 
Oesophagitis   7(8.1%)  79(91.9%) 
Gastritis   52(60.5%)  34(39.5%) 
Gastric ulcer   8(9.3%)  78(90.7%) 
Gastric cancer   3(3.5%)  83(96.5%) 
Duodenal ulcer   2(2.3%)  84(97.7%) 
Duodenitis  16(18.6%)  70(81.4%) 
Duodenogastric reflux  14(16.3%)  72(83.7%) 
Normal  18(20.9%)  68(79.1%) 
 
 
 
 
Table 2: Association between H. pylori status and presence of endoscopic abnormality in adult  Nigerian patients with 
dyspepsia 
   Endoscopic abnormality(n=86) 
Present  Absent  Total 
        
H. pylori  Positive  42 (76.4%)  13(23.6%)  55(100.0%) 
   Negative  26(83.9%)  5(16.1%)  31(100.0%) 
           
Total     68(79.1%)  18(20.9%)  86(100%) 
Chi-square = 0.675, df =1, P-value = 0.411  
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Table 3: Association between H. pylori status and various endoscopic abnormalities in adult Nigerian patients with dyspepsia 
Variables  H. pylori infection(n=86) 
   Positive  Negative  X
2  P-value 
            
Gastritis  Present  33(63.5%)  19(36.5%)     
Absent  22(64.7%)  12(35.3%)  0.014  0.906 
               
Serious gastroduodenal 
lesions+ 
Present  7(58.3%)  5(41.7%)     
Absent  48(35.1%)  26(64.9%)  0.191  0.662 
               
Duodenitis  Present  8(50%)  8(50.0%)     
Absent  47(67.1%)  23(32.9%)  1.660  0.198 
               
Doudenogastric reflux  Present  8(57.1%)  6(42.9%)     
Absent  47(65.3%)  25(34.7%)  1.336  0.562 
               
Oesophagitis  Present  6(85.7%)  1(14.3%)     
Absent  49(62.0%)  30(38.0%)  1.565  0.211* 
*Fisher’s exact test, +Gastric ulcer, duodenal ulcer and gastric cancer 
  
 